Davis Polk advised Laekna Therapeutics in the transaction.Laekna Therapeutics completed its $61 million Series D financing led by CS Capital with support from Worldstar, and Infinity Capital….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
